Keywords: Grifols, Talecris, Plasma, Divestitures, USA, FTC, Albumin, Immune globulin

Grifols must divest assets to complete acquisition of Talecris, says USA’s FTC

Article | 02 June 2011

Print This

The USA’s Federal Trade Commission will require Spanish firm Grifols (GRLS: MC), a manufacturer of plasma-derived drugs, to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in